Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 3 |
| List of Tables | 4 | 1 |
| List of Figures | 4 | 1 |
| Introduction | 5 | 1 |
| Global Markets Direct Report Coverage | 5 | 1 |
| Cholera Overview | 6 | 1 |
| Therapeutics Development | 7 | 2 |
| Pipeline Products for Cholera Overview | 7 | 1 |
| Pipeline Products for Cholera Comparative Analysis | 8 | 1 |
| Cholera Therapeutics under Development by Companies | 9 | 1 |
| Cholera Therapeutics under Investigation by Universities/Institutes | 10 | 1 |
| Cholera Pipeline Products Glance | 11 | 3 |
| Late Stage Products | 11 | 1 |
| Clinical Stage Products | 12 | 1 |
| Early Stage Products | 13 | 1 |
| Cholera Products under Development by Companies | 14 | 1 |
| Cholera Products under Investigation by Universities/Institutes | 15 | 1 |
| Cholera Companies Involved in Therapeutics Development | 16 | 2 |
| Beijing Minhai Biotechnology Co., Ltd | 16 | 1 |
| MSD Wellcome Trust Hilleman Laboratories, Pvt. Ltd. | 17 | 1 |
| Cholera Therapeutics Assessment | 18 | 9 |
| Assessment by Monotherapy Products | 18 | 1 |
| Assessment by Target | 19 | 2 |
| Assessment by Mechanism of Action | 21 | 2 |
| Assessment by Route of Administration | 23 | 2 |
| Assessment by Molecule Type | 25 | 2 |
| Drug Profiles | 27 | 13 |
| cholera (trivalent) vaccine Drug Profile | 27 | 1 |
| cholera [strain O1/El/Tor/Ogawa] vaccine Drug Profile | 28 | 1 |
| cholera vaccine Drug Profile | 29 | 1 |
| Cholvax Drug Profile | 30 | 1 |
| crofelemer DR Drug Profile | 31 | 3 |
| gram-negative bacterial infections vaccine Drug Profile | 34 | 1 |
| IMSUTMR-1501 Drug Profile | 35 | 1 |
| Peptide for Cholera and Guillain-Barre Syndrome Drug Profile | 36 | 1 |
| Small Molecules for Bacterial Infections Drug Profile | 37 | 1 |
| Small Molecules to Inhibit Sialic Acid Permease for Gram Negative Bacterial Infections Drug Profile | 38 | 1 |
| Synthetic Peptides to Disrupt Cell Membrane for Bacterial and Fungal Infections Drug Profile | 39 | 1 |
| Cholera Dormant Projects | 40 | 1 |
| Cholera Discontinued Products | 41 | 1 |
| Cholera Product Development Milestones | 42 | 2 |
| Featured News &Press Releases | 42 | 1 |
| Apr 27, 2016: Hilleman Laboratories Provides Phase I/II Update on Cholera Vaccine | 42 | 1 |
| Feb 03, 2015: Napo Files Brief on Appeal In Dispute With Salix | 42 | 2 |
| Appendix | 44 | 2 |
| Methodology | 44 | 1 |
| Coverage | 44 | 1 |
| Secondary Research | 44 | 1 |
| Primary Research | 44 | 1 |
| Expert Panel Validation | 44 | 1 |
| Contact Us | 44 | 1 |
| Disclaimer | 45 | 1 |